RNAC

Cartesian Therapeutics, Inc.

24.48 USD
-0.09 (-0.37%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Cartesian Therapeutics, Inc. stock is up 16.41% since 30 days ago. The next earnings date is Aug 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 7 May’s closed higher than April. 100% of analysts rate it a buy.

About Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc., formerly Selecta Biosciences, Inc., is a clinical-stage company, which is engaged in ribonucleic acid (RNA) cell therapies for the treatment of autoimmune diseases.

  • HC Wainwright & Co.
    Thu May 23, 06:49
    buy
    confirm
  • HC Wainwright & Co.
    Thu May 9, 15:22
    buy
    confirm
  • Needham
    Wed May 8, 11:38
    buy
    confirm